Join IDDO at this year’s WorldLeish7 conference

Organised by the PECET – Programa de Estudio y Control de Enfermedades Tropicales of the Universidad de Antioquia, Colombia, the conference runs from August 1 to 6, and aims to highlight new research, advances in treatment for VL and facilitate networking.

The conference includes a mix of keynote speakers, symposiums, pre-congress courses, poster presentations, meetings for thematic alliances and awards for student presentations.

Look out for IDDO’s presentations and poster sessions, including our symposium, #29, titled ‘A Global Visceral Leishmaniasis Data Platform’, which takes place on Thursday, August 4, from 11.30am to 1pm (COT) and will be led by IDDO’s Director Philippe Guerin and key members and observers of the IDDO Visceral Leishmaniasis (VL) Data Platform Scientific Advisory Committee (SAC). The presentations are:

• Professor Mitali Chatterjee, of the Institute of Postgraduate Medical Education & Research (IPGMER), who will discuss key challenges and opportunities
• Professor Ahmed Mudawi Musa, of the University of Khartoum, who will talk about Optimising historical data and planning prospectively
• Dr Fabiana Alves, of Drugs for Neglected Diseases initiative (DNDi), who discusses the Data platform potential for drug development
• Dr Saurabh Jain, World Health Organisation, who will talk about Impact on Policy
• Professor Philippe Guérin, IDDO Director, who will talk about the Future benefits of the VL Data Platform for research

Also from IDDO, Dr Caitlin Naylor will present the work of a global collaboration of the visceral leishmaniasis (VL) community to develop freely available, annotated VL case report forms (CRF) to accelerate research both into uncomplicated VL, and for patients with HIV-VL co-infection. The presentation takes place on Friday, August 5, in oral communications session 31, from 3.30pm to 4.30pm (COT) and is titled: Standardisation Of Data With Annotated Case Report Forms For Use In Visceral Leishmaniasis Clinical Trials In Patients With Or Without HIV Coinfection.

IDDO’s researchers will also present the following posters:

• Rutuja Chhajed -  ‘Estimating the proportion of relapse following treatment of Visceral Leishmaniasis (VL): Meta-analysis using IDDO living systematic review’ at poster session 2 on Wednesday, August 3, from 3.30pm to 4.30pm (COT)

• Dr Prabin Dahal – presents two posters, these are ‘Visceral Leishmaniasis in pregnancy: a systematic review’ at poster session 2 on Wednesday, August 3, from 3.30pm to 4.30pm (COT) and ‘Methodological variation in design and conduct of clinical studies in Visceral Leishmaniasis: A systematic review of published literature, 1980-2021’; at poster session 3, on Thursday, August 4, from 1pm to 2pm (COT)
• Dr Sauman Singh – ‘Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: a systematic review of clinical and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform’ poster session 2 on Wednesday, August 3, from 3.30pm to 4.30pm (COT)

For more information or to view the conference agenda view the WorldLeish7 website